本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ascendis Pharma A/S

160.45
+2.311.46%
盘后160.690.2400+0.15%19:24 EDT
成交量:37.23万
成交额:5,907.64万
市值:96.47亿
市盈率:-23.73
高:161.02
开:159.47
低:155.54
收:158.14
数据加载中...
2019/02/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/12

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/02/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/11

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/01/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/10/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/10/05

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/10/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/10/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/10/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]